Testing patients to allow tailored drug treatment
AUTOR(ES)
Leman, Peter
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=548736Documentos Relacionados
- Tailored Silica Nanoparticles Surface to Increase Drug Load and Enhance Bactericidal Response
- FDA may allow drug and device companies to promote “off-label” uses
- Adherence to drug treatment in hypertensive patients on the Family Health Program
- Two drug firms advertised to patients
- Two drug firms advertised to patients